CXCR4 and myocardial infarction: CXCR4 blockade by POL5551 promoted the mobilization of regulatory T cells, reduced the expression of inflammatory genes, enhanced angiogenesis in the infarcted region, and improved contractile dysfunction after myocardial infarction [14].